论文信息 - The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonists. - 字舞流文

The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonists.

A. Marfat | L. Melvin | H. Masamune | J. Eggler | John B. Cheng | J. Delehunt | R. J. Chambers | J. Watson | K. Cooper | D. B. Damon | John B. Cheng